NSG 533 - Advanced Pharmacology

EXAM ELABORATIONS Aug 28, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

NSG 533 - Advanced Pharmacology

Exam 2

Question:

NSAID use

Answer:

Nonselective COX-1 and COX-2 inhibitors (COX-2 does anti-inflammation)

Precaution: GI issues, renal toxicity, antiplatelet effect

No NSAID is better than others- but vary from patient to patient

Best for: RA, menstrual cramps, postsurgical pain, bony metastasis

Flat-dose curve response: higher doses aren't more effective than moderate

doses but do increase ADRs

ADRS: sodium retention, platelet inhibition, GI irritation, hepatic

dysfunction, renal insufficiency, CNS dysfunction

Caution: Diuretics, lithium, warfarin, nephrotoxicity, low creatinine

clearance, antihypertensives, reduced cardiac capacity

  • / 4

Question:

APAP

Answer:

Inhibit prostaglandin synthesis in CNS and block pain impulses in the periphery

Indication: mild-moderate pain including low back pain and osteoarthritis

Limits: hepatotoxicity don't go over 4000 mg/day, caution with alcohol use,

binge drinking

Renal dysfunction: 50-75% dose reduction and for those with excessive

ETOH use

Question:

Adjunctive pain medications

Answer:

Fibromyalgia: Duloxetine

Diabetic peripheral nerve pain (DPN): duloxetine, pregabalin (lyrica)

Post-herpetic neuralgia (PHN) (shingles): gabapentin, pregabalin, lidocaine

patch

  • / 4

Question:

Opioids

Answer:

Opioids act by stimulating opioid receptors in CNS

ADRs: Sedation, hallucinations, constipation, nausea, vomiting, urinary

retention, myoclonus, respiratory depression

Question:

Opioids ADR management

Answer:

Excessive sedation: reduce dose by 25% or change interval

Constipation: docusate at bedtime or BID, senna, bisacodyl, miralax,

methylnaltrexone, naloxegol N/V: prevention: hydroxyzine, diphenhydramine, treatment: prochlorperazine, ondansetron

Gastroparesis: metoclopramide

Vertigo: meclizine

Urticaria/itching: hydroxyzine, diphenhydramine

Respiratory depression: mild: reduce by 25%, moderate-severe: naloxone

CNS irritability: d/c opioid, treat with benzo

Patients with CYP450 may respond differently to opioids: drug

unresponsiveness - elevated toxic serum levels Tolerance to respiratory depression develops quickly

  • / 4

Question:

Opioid allergy

Answer:

Cross-sensitivity is unlikely

patient is truly allergic to one chemical class within the opioid family such as morphine-like agents they may try a different one such as meperidine-like or methadone-like agents

Mixed agonist/antagonist agents are treated as if they are morphine-like agents

Question:

Opioid conversion

Answer:

Opioid potency is compared using a reference standard of 10 mg parenteral morphine Current total daily dose is calculated (for 24 hours including any rescue dosages) and the total of the new dosage form is determined using a ratio of equianalgesic doses Sustained-release options may decrease by 25% due to oversedation concern Methadone is more potent than once believed and may need to be reduced after calculation as well as for elderly

  • / 4

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: EXAM ELABORATIONS
Added: Aug 28, 2025
Description:

NSG 533 - Advanced Pharmacology Exam 2 Question: NSAID use Answer: Nonselective COX-1 and COX-2 inhibitors (COX-2 does anti-inflammation) Precaution: GI issues, renal toxicity, antiplatelet effect ...

Get this document $30.00